#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Shprintzen-Goldberg syndrome Nephrotic syndrome Short stature Primary biliary cholangitis Blood iron increased Endometrial cancer recurrent Philadelphia positive acute lymphocytic leukaemia Warm autoimmune haemolytic anaemia Acquired C1 inhibitor deficiency Severe myoclonic epilepsy of infancy Acquired haemophilia Mantle cell lymphoma stage III Leukocyte adhesion deficiency type I Kawasaki's disease Hyperinsulinism More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Soft tissue sarcoma – Diagnostics Rett syndrome Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Diagnostics Lymphatic malformation Choroid melanoma – Trials in Disease Myxofibrosarcoma – Trials in Disease Richter’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZIGAKIBART Salbutamol Sulfate L-PROLINE Nicotinamide Bp Atrasentan Hydrochloride Bedaquiline Pertechnetate (99Mtc) Sodium Vgl101 Azd0901 Sunvozertinib Hydrocortisone CILOSTAZOL Oteracil Anastrozole Sodium S-Lactate Solution POLYMYXIN B SULFATE Buclizine Hydrochloride Terlipressin OMEGA-3-ACID ETHYL ESTERS 90 Prednisolone More therapies…

    Learn about Your Condition

    Systemic candida Pancoast's tumour Breast cancer male Ewing's sarcoma metastatic Delayed graft function Chronic lymphocytic leukaemia Hypereosinophilic syndrome Clinically isolated syndrome Cutaneous calcification Endocrine ophthalmopathy Liver transplant rejection Hypocalcaemia Bronchostenosis Peripheral artery restenosis Diminished ovarian reserve More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Groupe Hospitalier du Havre – Hôpital Jacques…

Groupe Hospitalier du Havre – Hôpital Jacques Monod

55 B Rue Gustave Flaubert, Montivilliers, 76600, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Landiolol Hydrochloride and Sodium Chloride for Reducing Mortality in Patients with Septic Shock and High Heart Rate

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Landiolol Hydrochloride
    • Sodium Chloride
    France

  • A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

    Recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    • Salbutamol Sulfate
    Belgium Bulgaria Denmark France Germany Greece +6

  • Effectiveness of Tenecteplase in Acute Ischemic Stroke Patients Treated 4.5–24 Hours After Onset Before Transfer for Thrombectomy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    France

  • Safety and efficacy of obinutuzumab in patients with active diffuse systemic sclerosis: a randomized, double-blind, placebo-controlled trial

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Obinutuzumab
    France

  • Early Saline Pleural Irrigation for Patients with Complicated Pleural Infections

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infectious pleural effusion
    Investigated Drugs:
    • Urokinase
    • Clindamycin Phosphate
    • Cefotaxime
    France

  • Rituximab versus placebo for maintenance therapy in adults with stabilized systemic sclerosis‑associated interstitial lung disease

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    • Rituximab
    • Sodium Chloride
    France

  • A study comparing bimekizumab and adalimumab for treating chest pain in patients with active axial spondyloarthritis who do not respond well to non-steroidal anti-inflammatory drugs.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Bimekizumab
    • Adalimumab
    France

  • Study of the effectiveness of iloprost compared to a placebo for treating vaso-occlusive crises in adults with sickle cell disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    • Sickle cell anaemia
    Investigated Drugs:
    • ILOPROST
    • Glucose Monohydrate
    France

  • Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Iberdomide
    • Carfilzomib
    • Dexamethasone
    Belgium France

  • A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Bulgaria Denmark France Germany Ireland Italy +3
Previous Page
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!